Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2005-05-10
2005-05-10
Kunz, Gary (Department: 1647)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C424S188100, C514S002600
Reexamination Certificate
active
06890535
ABSTRACT:
Disclosed are pharmaceutical compositions and methods for preventing or treating a number of amyloid diseases, including Alzheimer's disesase, prion diseases, familial amyloid neuropathies and the like. The pharmaceutical compositions include immunologically reactive amounts of amyloid fibril components, particularly fibril-forming peptides or proteins. Also disclosed are therapeutic compositions and methods which use immune reagents that react with such fibril components.
REFERENCES:
patent: 4666829 (1987-05-01), Glenner et al.
patent: 5004697 (1991-04-01), Pardridge
patent: 5057540 (1991-10-01), Kensil et al.
patent: 5187153 (1993-02-01), Cordell et al.
patent: 5192753 (1993-03-01), McGeer et al.
patent: 5208036 (1993-05-01), Eppstein et al.
patent: 5220013 (1993-06-01), Ponte et al.
patent: 5231000 (1993-07-01), Majocha et al.
patent: 5231170 (1993-07-01), Averback
patent: 5270165 (1993-12-01), Van Nostrand et al.
patent: 5387742 (1995-02-01), Cordell
patent: 5434170 (1995-07-01), Andrulis, Jr.
patent: 5441870 (1995-08-01), Seubert et al.
patent: 5571499 (1996-11-01), Hafler et al.
patent: 5571500 (1996-11-01), Hafler et al.
patent: 5583112 (1996-12-01), Kensil et al.
patent: 5585100 (1996-12-01), Mond et al.
patent: 5593846 (1997-01-01), Schenk et al.
patent: 5605811 (1997-02-01), Seubert et al.
patent: 5612486 (1997-03-01), McConlogue et al.
patent: 5622701 (1997-04-01), Berg
patent: 5641473 (1997-06-01), Hafler et al.
patent: 5641474 (1997-06-01), Hafler et al.
patent: 5645820 (1997-07-01), Hafler et al.
patent: 5679348 (1997-10-01), Nesburn et al.
patent: 5688651 (1997-11-01), Solomon
patent: 5733547 (1998-03-01), Weiner et al.
patent: 5736142 (1998-04-01), Sette et al.
patent: 5744368 (1998-04-01), Goldgaber et al.
patent: 5750349 (1998-05-01), Suzuki et al.
patent: 5753624 (1998-05-01), McMichael et al.
patent: 5776468 (1998-07-01), Hauser et al.
patent: 5780587 (1998-07-01), Potter
patent: 5786180 (1998-07-01), Konig et al.
patent: 5824322 (1998-10-01), Balasubramanian
patent: 5837473 (1998-11-01), Maggio et al.
patent: 5837672 (1998-11-01), Schenk et al.
patent: 5849298 (1998-12-01), Weiner et al.
patent: 5851996 (1998-12-01), Kline
patent: 5854204 (1998-12-01), Findeis et al.
patent: 5869054 (1999-02-01), Weiner et al.
patent: 5869093 (1999-02-01), Weiner et al.
patent: 5877399 (1999-03-01), Hsiao et al.
patent: 5935927 (1999-08-01), Vitek et al.
patent: 5955079 (1999-09-01), Mond et al.
patent: 5955317 (1999-09-01), Suzuki et al.
patent: 5958883 (1999-09-01), Snow
patent: 5989566 (1999-11-01), Cobb et al.
patent: 6057367 (2000-05-01), Slamler et al.
patent: 6114133 (2000-09-01), Seubert et al.
patent: 6150091 (2000-11-01), Pandolfo et al.
patent: 6262335 (2001-07-01), Hsiao et al.
patent: 6284221 (2001-09-01), Schenk et al.
patent: 6294171 (2001-09-01), McMichael
patent: 6417178 (2002-07-01), Klunk et al.
patent: 20010018053 (2001-08-01), McMichael
patent: 20020009445 (2002-01-01), Du et al.
patent: 20020077288 (2002-06-01), Frangione
patent: 20010102261 (2002-08-01), Raso
patent: 20020136718 (2002-09-01), Raso
patent: 20020162129 (2002-10-01), Lannfell
patent: 451 700 (1991-10-01), None
patent: 276 723 (1993-12-01), None
patent: 613 007 (1994-08-01), None
patent: 666 080 (1995-08-01), None
patent: 359 783 (1995-11-01), None
patent: 683 234 (1995-11-01), None
patent: 440 619 (1996-01-01), None
patent: 526 511 (1997-05-01), None
patent: 762 859 (1997-07-01), None
patent: 783 104 (1997-07-01), None
patent: 594 607 (1997-08-01), None
patent: 845 270 (1998-06-01), None
patent: 863 211 (1998-09-01), None
patent: 868 918 (1998-10-01), None
patent: 652 962 (1998-12-01), None
patent: 911 036 (1999-04-01), None
patent: 561 087 (1999-08-01), None
patent: 639 081 (1999-11-01), None
patent: 506 785 (2000-03-01), None
patent: 1 172 378 (2002-01-01), None
patent: 2 220 211 (1990-01-01), None
patent: 2 335 192 (1999-09-01), None
patent: WO 8810120 (1988-12-01), None
patent: WO 8901343 (1989-02-01), None
patent: WO 8903687 (1989-05-01), None
patent: WO 8906242 (1989-07-01), None
patent: WO 8906689 (1989-07-01), None
patent: WO 9012870 (1990-11-01), None
patent: WO 9012871 (1990-11-01), None
patent: WO 9108780 (1991-06-01), None
patent: WO 9112818 (1991-09-01), None
patent: WO 9116819 (1991-11-01), None
patent: WO 9116819 (1991-11-01), None
patent: WO 9119810 (1991-12-01), None
patent: WO 9206708 (1992-04-01), None
patent: WO 9208187 (1992-04-01), None
patent: WO 9213069 (1992-08-01), None
patent: WO 9302189 (1993-02-01), None
patent: WO 9304194 (1993-03-01), None
patent: WO 9314200 (1993-07-01), None
patent: WO 9315760 (1993-08-01), None
patent: WO 9316724 (1993-09-01), None
patent: WO 9321950 (1993-11-01), None
patent: WO 9401772 (1994-01-01), None
patent: WO 9403615 (1994-02-01), None
patent: WO 9428412 (1994-12-01), None
patent: WO 9504151 (1995-02-01), None
patent: WO 9505853 (1995-03-01), None
patent: WO 9511008 (1995-04-01), None
patent: WO 9511311 (1995-04-01), None
patent: WO 9511994 (1995-05-01), None
patent: WO 9512815 (1995-05-01), None
patent: WO 9531996 (1995-11-01), None
patent: WO 9618900 (1996-06-01), None
patent: WO 9625435 (1996-08-01), None
patent: WO 9628471 (1996-09-01), None
patent: WO 9639176 (1996-12-01), None
patent: WO 9717613 (1997-05-01), None
patent: WO 9721728 (1997-06-01), None
patent: WO 9807850 (1998-02-01), None
patent: WO 9844955 (1998-10-01), None
patent: WO 9900150 (1999-01-01), None
patent: WO 9906545 (1999-02-01), None
patent: WO 9908066 (1999-02-01), None
patent: WO 9927911 (1999-06-01), None
patent: WO 9927944 (1999-06-01), None
patent: WO 9927949 (1999-06-01), None
patent: WO 9900021 (1999-11-01), None
patent: WO 9906545 (1999-11-01), None
patent: WO 9958564 (1999-11-01), None
patent: WO 9960024 (1999-11-01), None
patent: WO 9960024 (1999-11-01), None
patent: WO 0162284 (2000-03-01), None
patent: WO 0043039 (2000-07-01), None
patent: WO 0043049 (2000-07-01), None
patent: WO 0072870 (2000-12-01), None
patent: WO 0072876 (2000-12-01), None
patent: WO 0072876 (2000-12-01), None
patent: WO 0072880 (2000-12-01), None
patent: WO 0072880 (2000-12-01), None
patent: WO 0077178 (2000-12-01), None
patent: WO 0203911 (2001-04-01), None
patent: WO 0142306 (2001-05-01), None
patent: WO 0139796 (2001-06-01), None
patent: WO 0162801 (2001-08-01), None
patent: WO 0177167 (2001-10-01), None
patent: WO 0190182 (2001-11-01), None
patent: WO 0234878 (2002-05-01), None
patent: WO 0234777 (2002-06-01), None
Andersen et al., “Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?,”Neurology,45:1441-1445 (1995).
Associated Press, “Immune cells may promote Alzehimer's, a study finds,”The Boston Globe(Apr. 13, 1995).
Bard et al., “Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease,”Nature Medicine,6(8):916-919 (2000).
Barrow, et al., “Solution Conformations and aggregational Properties of Synthetic Amyloid Beta-Peptides of Alzheimer's Disease. Analysis of Circular Dichroism Spectra”,J. Mol. Biol.,225(4): 1075-1093 (1992).
Bauer et al., “Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices,”FEBS Letters,285(1):111-114 (1991).
Beasley, “Alzheimer's traced to proteins caused by aging,” Reuters, Apr. 20, 2001 7:56 PM ET.
Bercovici et al., “Chronic Intravenous Injections of Antigen Induce and Maintain Tolerance in T Cell Receptor-Transgenic Mice,”Eur. J. Immunol.29:345-354 (1999).
Bickel et al., “Site Protected, Cationized Monoclonal Antibody Against Beta Amyloid as a Potential Diagnostic Imaging Technique for Alzheimer's Diseases,”Soc. for Neuroscience Abstracts18:764 (1992).
Blass, John P., “Immunologic Treatment of Alzheimer's Disease,”New England J. Medicine,341 (22):1694 (1999).
Bodmer et al., “Transforming Growth Factor-Beta Bound to Soluble Derivatives of the Beta Amyloid Precursor Protein of Alzheimer's Disease,”Biochem. Biophys. Res. Com
Kunz Gary
Neuralab Limited
Nichols Christopher James
LandOfFree
Pharmaceutical compositions and methods for treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions and methods for treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions and methods for treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3388547